MiMedx Group Inc MDXG:NASDAQ

Last Price$5.12NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/14/22

Today's Change+0.08(1.59%)
Bid (Size)$5.11 (41)
Ask (Size)$5.12 (247)
Day Low / High$4.80 - 5.14
Volume750.5 K

View Biotechnology IndustryPeer Comparison as of 01/14/2022


MiMedx Group Inc ( NASDAQ )

Price: $5.12
Change: +0.08 (1.59%)
Volume: 750.5 K
4:00PM ET 1/14/2022

BioXcel Therapeutics Inc ( NASDAQ )

Price: $19.50
Change: +0.05 (0.26%)
Volume: 428.5 K
4:00PM ET 1/14/2022

Karyopharm Therapeutics Inc ( NASDAQ )

Price: $8.04
Change: +0.01 (0.12%)
Volume: 2.3 M
4:00PM ET 1/14/2022

bluebird bio Inc ( NASDAQ )

Price: $8.73
Change: +0.21 (2.46%)
Volume: 2.3 M
4:00PM ET 1/14/2022

VBI Vaccines Inc ( NASDAQ )

Price: $2.05
Change: +0.14 (7.33%)
Volume: 2.6 M
4:00PM ET 1/14/2022

Read more news Recent News

MiMedx Lifts Adjusted Net Sales Outlook for FY21
7:54AM ET 12/07/2021 MT Newswires

MiMedx Group, Inc (MDXG) said Tuesday it now expects adjusted net sales for the fiscal year 2021 to be between $253 million and $258 million, higher than...

Top Premarket Decliners
8:16AM ET 11/26/2021 MT Newswires

MiMedx Group (MDXG) shares slumped 21% following a muted session. Pinduoduo (PDD) shares fell 19% even after the company posted improved Q3 earnings...

-- Earnings Flash (MDXG) MIMEDX GROUP Posts Q3 Revenue $63.1M, vs. Street Est of $60.3M
4:51PM ET 11/02/2021 MT Newswires


HC Wainwright Adjusts Price Target for MiMedx Group to $8.50 From $20, Maintains Buy Rating
10:16AM ET 9/14/2021 MT Newswires

MiMedx Group, Inc (MDXG) has an average investment rating of buy among analysts polled by Capital IQ, with a price target range of $17 to $23. (MT...

Company Profile

Business DescriptionMiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane; EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matri derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA. View company web site for more details
Address1775 West Oak Commons Court NE
Marietta, Georgia 30062
Number of Employees690
Recent SEC Filing01/10/20228-K
Chief Executive Officer & DirectorTimothy R. Wright
Senior Vice President-Operations & ProcurementScott M. Turner
Chief Financial OfficerPeter M. Carlson
Chief Medical OfficerDavid H. Mason

Company Highlights

Price Open$5.00
Previous Close$5.04
52 Week Range$4.80 - 15.99
Market Capitalization$574.2 M
Shares Outstanding112.1 M
SectorHealth Technology
Next Earnings Announcement03/14/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.31
Beta vs. S&P 500N/A
Revenue$245.0 M
Net Profit Margin-11.20%
Return on Equity-33.48%

Analyst Ratings as of 07/23/2021

Consensus RecommendationConsensus Icon
Powered by Factset